Stemson Therapeutics is a biotechnology startup founded in 2018 in the United States. With the slogan "Regenerate Hair, Rejuvenate Life," the company is dedicated to providing a solution for individuals facing the emotional and social challenges of hair loss. Their vision is to offer a safe and effective cure for hair loss, enabling people to naturally restore their hair. Stemson Therapeutics recently secured a significant $15.00M Series A investment on 15 July 2021, with notable investors including Genoa Ventures, AbbVie Biotech Ventures, and DCVC Bio. This investment reflects the confidence of key players in the biotech industry in the potential of Stemson Therapeutics' innovative approach and lays a strong foundation for the company's future growth and development.
No recent news or press coverage available for Stemson Therapeutics .